SnagRx Review: Is It Legit?

SnagRx is an online weight-loss program that sells compounded GLP-1 injections on a subscription. "SnagRx allows you to get prescription weight loss medications such as semaglutide & tirzepatide from the comfort of your home."

Here is how it goes. You answer a short health qualifier, then fill in a medical intake in the patient portal. A provider from OpenLoop Health, a network of US-licensed doctors, reviews your chart. If a GLP-1 fits, a partner pharmacy fills the prescription. The medication ships free and arrives in 1-2 days. Refills are requested through the portal.

The menu has two drugs, both compounded and both weekly injections: semaglutide and tirzepatide. There is no brand-name option. The medical practice behind the service is Modern Metabolic Medicine.

Compounded means a pharmacy makes the drug to a prescription. It is not an FDA-approved product, and that is the trade for the low price. To understand the drugs themselves, read our pages on semaglutide and tirzepatide. SnagRx serves every US state except Louisiana, and in Nebraska only patients 19 and over.

Yes. SnagRx names its prescriber network, OpenLoop Health, and the four pharmacies that fill its prescriptions. It has no FDA warning letter and no open flag. That is more disclosure than we usually see from a compounded program, and the record behind it is clean.

The four pharmacies are RedRock, Health Warehouse, Precision Compounding and Triad Rx. "Medications prescribed through SnagRx are dispensed by U.S.-based 503A compounding pharmacies." Those pharmacies compound a drug for one named patient on a prescription, and state boards oversee them. Outsourcing facilities, which make drugs in bulk, register with the FDA instead. None of the four names appears in the FDA register we read, which is normal for this pharmacy type.

The site says plainly that the drugs are compounded. It says they are "prescribed by a doctor and compounded by a real US based pharmacy." Traceability scores 9 out of 10.

SnagRx costs $99 a month all-in for compounded semaglutide on the monthly plan, and $149 a month for compounded tirzepatide. The medication, the provider and the shipping are included, with no other fee.

Longer plans cost less. Semaglutide is $89 a month on a 3-month plan, billed as $267 once. On a 12-month plan, semaglutide is $69 a month, billed as $828 once. Tirzepatide is $119 a month on a 12-month plan, billed as $1,428 once. The home page leads with "Semaglutide for $69 / Tirzepatide for $119", and those are the 12-month rates.

The price stays the same as your dose rises. The terms, last updated July 27, 2026, set out each plan. They also note that "The final charge may vary based on the prescribed medication and the selected pharmacy".

There is nothing on top. The membership fee, the consultation fee and the shipping fee are each $0. SnagRx does not bill insurance. Three months at the monthly semaglutide rate total $297.

That puts SnagRx at rank 2 of the 18 compounded programs in its group on month-to-month prices. The median there is $179 a month. For scale, a pharmacy pays $871.12 for a Wegovy 1.7 mg pen package, effective September 23, 2026. That is an acquisition cost for the brand-name drug, not what a patient pays.

The care runs through a nursing team and a patient portal, not scheduled video visits. A provider reviews your chart within 24 hours, often in under 5 hours. No appointment is needed.

Medication ships within 2 business days of approval, and orders before 2pm central ship the same day. From there, the SnagRx nursing staff gives you ongoing 1:1 medical support. You request each refill in the portal, and the provider reviews your dose each time. "Our providers will do their best to match you with the dosage that best fits your needs and journey." Phone and email support are also available.

SnagRx does not state whether it asks for labs. Clinical care scores 8.6 out of 10, and a stated lab policy is what would lift it.

SnagRx has no FDA warning letter and no open flag on its record. None of its four pharmacies appears in the letters we hold. Its record is clean.

The safety question with a compounded program is the drug itself. A compounded GLP-1 is made by a pharmacy, and the FDA does not review it the way it reviews Wegovy or Zepbound. SnagRx's intake carries a note of its own: "For those taking Tirzepatide , we recommend switching to a non-oral contraceptive method or adding a barrier method of contraception for four weeks after initiation and for four weeks after each dose escalation."

For side effects, doses and who should not take these drugs, read our semaglutide and tirzepatide pages, which quote the FDA labels. Safety scores 10 out of 10 on this record.

It depends on the plan. The monthly plans cancel at any time, with no minimum term. The 12-month plans carry a 12-month commitment, so the $69 and $119 rates come with a lock.

All payments are final: the only refund is when a provider finds you are not clinically eligible. In that case, SnagRx refunds the unused part of your current term. SnagRx also makes no promise about results.

So the trap is simple. Do not prepay $828 or $1,428 for the headline rate unless you are sure you will stay on the drug for a year. Terms score 8 out of 10: the monthly plans are clean, the annual lock costs the rest.

SnagRx publishes no customer testimonials on the pages we read. The site sells on price and speed instead: a $69 headline rate, a provider review in under a day and delivery in 1-2 days.

This site collects no independent reviews, so there are no patient stories here to weigh. Look at independent reviews for how support and refills go in practice. The prices and terms above tell you what you will pay and what you sign. Ask how SnagRx handles a dose change before you commit to a long plan.

Price transparency scores 10 at a 20% weight: every fee is $0, every price held on re-read, and the 12-month rates are labeled. Cost and value scores 10 at a 15% weight: rank 2 of 18 on month-to-month prices, no fee load. Traceability scores 9 at a 15% weight: four pharmacies named and their type stated, none found in the FDA register. Clinical care scores 8.6 at a 15% weight: a named prescriber network and a stated wait time, no lab policy.

Safety scores 10 at a 20% weight: no letter, no flag, a clean record. Terms score 8 at a 10% weight: monthly plans cancel anytime, the 12-month plans do not. Availability scores 9.88 at a 5% weight: 48 states and free shipping.

Our fresh computation gives 9.4, a move of 0.1. That is under our 0.3 threshold, so the published 9.3 stands until a later crawl confirms it. Since our last check, price transparency rose from 9 to 10 and clinical care from 7.6 to 8.6. Terms fell from 10 to 8 after the refund page changed. The weights are on our methodology page.